Discover 2,262 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Francisco offers opportunities for individuals interested in taking part in paid studies as healthy volunteers, as well as those looking for studies for a specific medical condition. The city has a strong emphasis on cutting-edge research for conditions such as HIV/AIDS, oncology, kidney disease, PCOS, and endometriosis, among others. By participating, you can gain access to the latest healthcare innovations and contribute to pioneering medical progress.
Filter
2
Filter results
Results: 2,262
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
for
Uncontrolled Hypertension
Location: San Jose CA, Ventura CA, West Hills CA, Pasadena CA,
Sponsor: Retension Pharmaceuticals. Inc.
Sex: All
Age: 18 - 70+
Code: NCT07142356
Phase 2, Recruiting
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Palo Alto CA, Los Angeles CA, La Jolla CA,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase 2, Phase 3, Recruiting
Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
for
Hodgkin Lymphoma
Location: Stanford CA, Vancouver, Winnipeg, Hamilton, Toronto,
Sponsor: University College, London
Sex: All
Age: 16 - 69
Code: NCT04685616
Phase 3, Recruiting
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
for
Low Risk Myelodysplastic Syndromes
Location: Palo Alto CA, Los Angeles CA, Orange CA,
Sponsor: Rigel Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05308264
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling
for
Human Papilloma Virus
Location: Sunnyvale CA
Sponsor: Atila Biosystems Inc.
Sex: Female
Age: 30 - 64
Code: NCT07232355
Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Palo Alto CA, Duarte CA, Westwood KS, Houston TX,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06034002
Phase 1, Recruiting
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
for
Non Small Cell Lung Cancer, Triple Negative Breast Cancer,
Location: Palo Alto CA, Spokane WA, Nashville TN, Fort Wayne IN,
Sponsor: Compass Therapeutics
Sex: All
Age: 18+
Code: NCT06150664
Phase 1, Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Palo Alto CA, Santa Barbara CA, Los Angeles CA,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18+
Code: NCT06690775
Phase 2, Recruiting
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
for
Thymoma, Thymic Carcinoma
Location: Palo Alto CA, Chicago IL, Washington D.C. DC,
Sponsor: Georgetown University
Sex: All
Age: 18+
Code: NCT06248515
Phase 2, Recruiting
Food Allergy Registry at a Single Site
for
Allergy and Asthma
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 0 - 70+
Code: NCT03539705
Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
for
Advanced Systemic Mastocytosis (AdvSM),
Location: Stanford CA, Los Angeles CA, Duarte CA,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT04996875
Phase 2, Recruiting
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
for
Indolent Systemic Mastocytosis,
Location: Palo Alto CA, Los Angeles CA, La Jolla CA,
Sponsor: Blueprint Medicines Corporation
Sex: All
Age: 18+
Code: NCT04910685
Phase 2, Phase 3, Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Stanford CA, Newport Beach CA, Dallas TX, Rochester MN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase 1, Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: Palo Alto CA, Sacramento CA, Santa Barbara CA,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07173751
Phase 3, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Palo Alto CA, Reno NV, Santa Barbara CA, Burbank CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase 3, Recruiting
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
for
Coronary Artery Disease (CAD)
Location: Palo Alto CA, Portland OR, Saint Cloud MN,
Sponsor: HeartFlow, Inc.
Sex: All
Age: 18+
Code: NCT07479433
Recruiting
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
for
Stage III Ovarian Cancer, Stage IV Ovarian Cancer,
Location: Palo Alto CA, Duarte CA, Newport Beach CA, La Jolla CA,
Sponsor: GOG Foundation
Sex: Female
Age: 18+
Code: NCT05659381
Phase 3, Recruiting
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
for
T-cell NHL (PTCL or CTCL)
Location: Stanford CA, Houston TX, St Louis MO, New York NY
Sponsor: Kyowa Kirin, Inc.
Sex: All
Age: 18+
Code: NCT07192471
Phase 1, Recruiting
Caring Recharge Project for Caregivers of Individuals With Alzheimer's Disease